Cargando…
Myelodysplastic syndrome versus idiopathic cytopenia of undetermined significance: the role of morphology in distinguishing between these entities
Autores principales: | dos Santos, Talyta Ellen de Jesus, Gonçalves, Romélia Pinheiro, Duarte, Fernando Barroso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e Hemoterapia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905828/ https://www.ncbi.nlm.nih.gov/pubmed/24478612 http://dx.doi.org/10.5581/1516-8484.20130069 |
Ejemplares similares
-
Idiopathic cytopenia of undetermined significance and systemic lupus
erythematosus
por: Gonçalves, Romelia Pinheiro, et al.
Publicado: (2013) -
Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes
por: Nielsen, Amalie Bach, et al.
Publicado: (2022) -
LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
por: Kaastrup, Katja, et al.
Publicado: (2023) -
Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
por: Choi, Eun-Ji, et al.
Publicado: (2021) -
Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
por: Duarte, Fernando Barroso, et al.
Publicado: (2014)